Goldman Sachs [GS] vs Morgan Stanley [MS] Detailed Stock Comparison
Goldman Sachs
NYSE
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Goldman Sachs wins in 10 metrics, Morgan Stanley wins in 8 metrics, with 0 ties. Goldman Sachs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Goldman Sachs | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.10 | 16.36 | Goldman Sachs |
| Price-to-Book Ratio | 1.94 | 2.35 | Goldman Sachs |
| Debt-to-Equity Ratio | 588.39 | 438.54 | Morgan Stanley |
| PEG Ratio | 0.61 | 1.01 | Goldman Sachs |
| Profit Margin (TTM) | 28.40% | 22.49% | Goldman Sachs |
| Operating Margin (TTM) | 35.74% | 34.12% | Goldman Sachs |
| EBITDA Margin (TTM) | 35.74% | 34.12% | Goldman Sachs |
| Return on Equity | 12.74% | 14.13% | Morgan Stanley |
| Return on Assets (TTM) | 0.90% | 1.16% | Morgan Stanley |
| Free Cash Flow (TTM) | $-15.30B | $-2.10B | Morgan Stanley |
| Dividend Yield | 1.42% | 2.15% | Morgan Stanley |
| 1-Year Return | 41.61% | 41.40% | Goldman Sachs |
| Price-to-Sales Ratio (TTM) | 4.04 | 3.52 | Morgan Stanley |
| Enterprise Value | $-24.36B | $157.91B | Morgan Stanley |
| EV/Revenue Ratio | -0.45 | 2.41 | Goldman Sachs |
| Revenue per Share (TTM) | $171 | $41 | Goldman Sachs |
| Earnings per Share (Diluted) | $45.38 | $8.84 | Goldman Sachs |
| Beta (Stock Volatility) | 1.37 | 1.32 | Morgan Stanley |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Goldman Sachs vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Goldman Sachs | -1.31% | -2.96% | 2.18% | 17.81% | 7.97% | 25.46% |
| Morgan Stanley | -0.49% | -2.19% | 2.56% | 10.11% | 2.40% | 15.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Goldman Sachs | 41.61% | 114.44% | 247.30% | 284.22% | 416.19% | 557.29% |
| Morgan Stanley | 41.40% | 65.96% | 172.40% | 323.11% | 475.59% | 179.42% |
Performance & Financial Health Analysis: Goldman Sachs vs Morgan Stanley
| Metric | GS | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $221.20B | $230.88B |
| Market Cap Category | Mega cap | Mega cap |
| 10 Day Avg. Volume | 1,645,470 | 4,647,290 |
| 90 Day Avg. Volume | 1,992,140 | 5,372,360 |
| Last Close | $721.38 | $144.07 |
| 52 Week Range | $439.38 - $749.05 | $94.09 - $149.08 |
| % from 52W High | -3.69% | -3.36% |
| All-Time High | $749.05 (Aug 15, 2025) | $148.81 (Aug 15, 2025) |
| % from All-Time High | -3.69% | -3.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.11% |
| Quarterly Earnings Growth | 0.22% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.28% | 0.22% |
| Operating Margin (TTM) | 0.36% | 0.34% |
| Return on Equity (TTM) | 0.13% | 0.14% |
| Debt to Equity (MRQ) | 588.39 | 438.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $376.89 | $61.59 |
| Cash per Share (MRQ) | $3,402.82 | $352.68 |
| Operating Cash Flow (TTM) | $-22,851,999,744 | $-17,670,000,640 |
| Levered Free Cash Flow (TTM) | $13.53B | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.42% | 2.15% |
| Last 12-Month Dividend | $9.00 | $2.79 |
Valuation & Enterprise Metrics Analysis: Goldman Sachs vs Morgan Stanley
| Metric | GS | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.10 | 16.36 |
| Forward P/E | 17.58 | 18.24 |
| PEG Ratio | 0.61 | 1.01 |
| Price to Sales (TTM) | 4.04 | 3.52 |
| Price to Book (MRQ) | 1.94 | 2.35 |
| Market Capitalization | ||
| Market Capitalization | $221.20B | $230.88B |
| Enterprise Value | $-24,364,414,976 | $157.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.45 | 2.41 |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | 1.37 | 1.32 |
| Book Value per Share (MRQ) | $376.89 | $61.59 |
Financial Statements Comparison: Goldman Sachs vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GS | MS |
|---|---|---|
| Revenue/Sales | $15.06B | $16.52B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $5.65B | $5.54B |
| Income Tax | $909.00M | $1.17B |
| Net Income (Profit) | $4.74B | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GS | MS |
|---|---|---|
| Cash & Equivalents | $167.41B | $60.84B |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $271.73B | $303.93B |
| Total Shareholders Equity | $124.30B | $107.85B |
| Retained Earnings | $157.02B | $107.65B |
| Property, Plant & Equipment | $24.59B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GS | MS |
|---|---|---|
| Operating Cash Flow | $11.67B | $-67.29B |
| Capital Expenditures | $-354.00M | $-713.00M |
| Free Cash Flow | $-37.73B | $-24.69B |
| Debt Repayment | $-17.14B | $-20.85B |
| Common Stock Repurchase | $-4.36B | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | GS | MS |
|---|---|---|
| Shares Short | 5.98M | 14.60M |
| Short Ratio | 2.65 | 2.55 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 1,645,470 | 4,647,290 |
| Average Daily Volume (90 Day) | 1,992,140 | 5,372,360 |
| Shares Outstanding | 310.65M | 1.61B |
| Float Shares | 286.92M | 1.21B |
| % Held by Insiders | 0.01% | 0.24% |
| % Held by Institutions | 0.75% | 0.63% |
Dividend Analysis & Yield Comparison: Goldman Sachs vs Morgan Stanley
| Metric | GS | MS |
|---|---|---|
| Last 12-Month Dividend | $9.00 | $2.79 |
| Last 12-Month Dividend Yield | 1.42% | 2.15% |
| 3-Year Avg Annual Dividend | $9.08 | $3.10 |
| 3-Year Avg Dividend Yield | 0.67% | 0.90% |
| 3-Year Total Dividends | $27.25 | $9.31 |
| Ex-Dividend Date | Feb 28, 2025 | Jan 31, 2025 |